Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. The firm's multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
202
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Rocket Pharmaceuticals Inc market cap is $235.6M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rocket Pharmaceuticals Inc 52 week high is $5.45 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rocket Pharmaceuticals Inc 52 week low is $2.03 as of November 18, 2026.
Rocket Pharmaceuticals Inc stock price today is $2.11.
Rocket Pharmaceuticals Inc stock price yesterday was $2.11.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Rocket Pharmaceuticals Inc's P/E ratio is -13.01.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Rocket Pharmaceuticals Inc P/B ratio is 0.7193.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Rocket Pharmaceuticals Inc 50-day moving average is $2.65.